XI’AN, CHINA -- (MARKET WIRE) -- January 24, 2007 -- Skystar Bio-Pharmaceutical (OTCBB: SKBI), a leading bio-pharmaceutical company in China, today announced that it has entered into an agreement with TNI-Penta for research and development of new veterinary pharmaceutical products. The new products are to be based on the efficacy of Methionine Enkephalin (MEK) for use in veterinary medicine.
